NCT05033925View on ClinicalTrials.gov

Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2025

Conditions
Breast Cancer Stage IV
Interventions
DIETARY_SUPPLEMENT

FADA (active fraction of Ficus septica leaf) 800 mg/day

FADA is given twice a day (total dose of 800 per day per patient)

DIETARY_SUPPLEMENT

FADA (active fraction of Ficus septica leaf) 2000 mg/day

FADA is given twice a day (total dose of 2000 per day per patient)

OTHER

Placebo capsule

Placebo capsule is given twice a day

Trial Locations (1)

Unknown

RECRUITING

Dr. Kariadi General Hospital, Semarang

All Listed Sponsors
collaborator

Ahmad Dahlan University

UNKNOWN

collaborator

Dr. Kariadi General Hospital

UNKNOWN

collaborator

PT Konimex

UNKNOWN

collaborator

LPDP, Kementerian Keuangan, Indonesia

UNKNOWN

lead

Gadjah Mada University

OTHER